Literature DB >> 8980953

Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma.

N Powell1, M Humbert, S R Durham, B Assoufi, A B Kay, C J Corrigan.   

Abstract

The selective recruitment of eosinophils into the mucosal lining of the airways is a prominent feature of atopic asthma, and is believed to be an important component in the disease pathogenesis. The precise stimuli responsible for the influx of eosinophils remain unclear. Using a semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR) technique, the numbers of copies (relative to the "housekeeping" gene beta-actin) of messenger ribonucleic acid (mRNA) encoding the eosinophil-active chemotactic cytokines, the factor regulated upon activation in normal T-cells expressed and secreted (RANTES) and monocyte chemotactic protein-3 (MCP-3), was measured in bronchial biopsies from atopic asthmatic patients (n = 9), and compared with atopic nonasthmatic (n = 8) and nonatopic nonasthmatic (n = 8) control subjects. In addition, further biopsies from each subject were prepared for immunohistochemistry and the numbers of activated (EG2+) eosinophils measured. The expression of RANTES mRNA was significantly elevated in the atopic asthmatic group as compared to the atopic nonasthmatic controls (p = 0.013) and the nonatopic nonasthmatic controls (p = 0.007). Similarly, the expression of mRNA encoding MCP-3 was significantly elevated in the atopic asthmatic group, relative to the atopic nonasthmatic controls (p = 0.014) and the nonatopic nonasthmatic control group (p = 0.011). Elevated RANTES and MCP-3 mRNA expression was associated with significantly increased numbers of bronchial mucosal eosinophils in the atopic asthmatic patients as compared to the atopic nonasthmatic (p = 0.03) and nonatopic nonasthmatic (p = 0.006) control subjects. In conclusion, we have identified elevated expression of messenger ribonucleic acid encoding RANTES and monocyte chemotactic protein-3 in the bronchial mucosa of atopic asthmatic patients relative to controls. These findings are compatible with the hypothesis that eosinophil-active beta-chemokines play a role in the mechanism of eosinophil recruitment to the asthmatic bronchial mucosa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980953     DOI: 10.1183/09031936.96.09122454

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  19 in total

1.  Increased CCL24/eotaxin-2 with postnatal ozone exposure in allergen-sensitized infant monkeys is not associated with recruitment of eosinophils to airway mucosa.

Authors:  Debbie L Chou; Joan E Gerriets; Edward S Schelegle; Dallas M Hyde; Lisa A Miller
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-12       Impact factor: 4.219

2.  The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4delta2, IL-2, and IFNgamma in asthma.

Authors:  E M Glare; M Divjak; M J Bailey; E H Walters
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

3.  Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa.

Authors:  J Wedemeyer; A Lorentz; M Göke; P N Meier; P Flemming; C A Dahinden; M P Manns; S C Bischoff
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

4.  Association analysis of interleukin 5 receptor alpha subunit (IL5RA) polymorphisms and asthma.

Authors:  Hyun Sub Cheong; Lyoung Hyo Kim; Byung Lae Park; Yoo Hyun Choi; Hae-Sim Park; Soo-Jong Hong; Byoung Whui Choi; Choon-Sik Park; Hyoung Doo Shin
Journal:  J Hum Genet       Date:  2005-10-06       Impact factor: 3.172

5.  Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.

Authors:  A H Lee; J H Hong; Y S Seo
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

6.  Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation.

Authors:  T W Wright; C J Johnston; A G Harmsen; J N Finkelstein
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

7.  The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis.

Authors:  Silvia Alvarez-Diaz; Christopher P Dillon; Najoua Lalaoui; Maria C Tanzer; Diego A Rodriguez; Ann Lin; Marion Lebois; Razq Hakem; Emma C Josefsson; Lorraine A O'Reilly; John Silke; Warren S Alexander; Douglas R Green; Andreas Strasser
Journal:  Immunity       Date:  2016-08-11       Impact factor: 31.745

8.  Intelectin is required for IL-13-induced monocyte chemotactic protein-1 and -3 expression in lung epithelial cells and promotes allergic airway inflammation.

Authors:  Naibing Gu; Guannan Kang; Chang'E Jin; Yongjian Xu; Zhenxiang Zhang; David J Erle; Guohua Zhen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-04       Impact factor: 5.464

9.  The Fli-1 transcription factor regulates the expression of CCL5/RANTES.

Authors:  Mara L Lennard Richard; Shuzo Sato; Eiji Suzuki; Sarah Williams; Tamara K Nowling; Xian K Zhang
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

10.  Eosinophil recruitment in type-2 hypersensitivity pulmonary granulomas: source and contribution of monocyte chemotactic protein-3 (CCL7).

Authors:  Xiao-Zhou Shang; Bo-Chin Chiu; Valerie Stolberg; Nicholas W Lukacs; Steven L Kunkel; Hedwig S Murphy; Stephen W Chensue
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.